In the case for PCa treatment however, an intrinsic problem with ADT is that the tumor epithelial cells are the desired targets, but the stroma will also be targeted, which will induce a more lethal microenvironment since AR in stroma is required for a healthy phenotype. This evidence concerns the gene AR and posterior cortical atrophy.